Commonwealth Equity Services
AYTU icon

Commonwealth Equity Services’s AYTU BioPharma AYTU Stock Holding History

Commonwealth Equity Services’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,637
Closed -$35 – 3839
2023
Q1 		$35 Buy
15,637
+159
+1% +$465 ﹤0.01% 3615
2022
Q4 		$58K Buy
15,478
+5,000
+48% +$18.8K ﹤0.01% 3499
2022
Q3 		$38K Buy
10,478
+4,993
+91% +$37.9K ﹤0.01% 3512
2022
Q2 		$75K Sell
5,485
-4
-0.1% -$51 ﹤0.01% 3418
2022
Q1 		$118K Buy
5,489
+100
+2% +$2.49K ﹤0.01% 3448
2021
Q4 		$145K Buy
5,389
+3
+0.1% +$130 ﹤0.01% 3378
2021
Q3 		$310K Buy
5,386
+2,496
+86% +$187K ﹤0.01% 2884
2021
Q2 		$289K Buy
2,890
+560
+24% +$65.7K ﹤0.01% 2934
2021
Q1 		$354K Buy
2,330
+1,095
+89% +$174K ﹤0.01% 2618
2020
Q4 		$147K Buy
1,235
+497
+67% +$90.5K ﹤0.01% 2994
2020
Q3 		$175K Buy
738
+303
+70% +$77.9K ﹤0.01% 2768
2020
Q2 		$123K Buy
435
+299
+220% +$90.5K ﹤0.01% 2738
2020
Q1 		$40K Buy
+136
New +$26.3K ﹤0.01% 2706

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Commonwealth Equity Services's AYTU Position: Q2 2023 in Review

Commonwealth Equity Services sold out of AYTU BioPharma (AYTU) in Q2 2023, closing a stake of 15,637 shares — an estimated $35 sold.

Commonwealth Equity Services first reported a position in AYTU in Q1 2020 and held it in 13 quarters. The position peaked at $354K in Q1 2021. 21 funds tracked by Wall St. Rank hold AYTU as of Q2 2023.

  • Commonwealth Equity Services reported no remaining AYTU BioPharma position as of Q2 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 15,637 AYTU BioPharma shares in Q2 2023, an estimated $35.
  • Commonwealth Equity Services first reported a position in AYTU BioPharma in Q1 2020 and held it in 13 quarters.
  • Commonwealth Equity Services's AYTU BioPharma position peaked at $354K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2023.

Based on Commonwealth Equity Services's 13F filing for Q2 2023, filed 10 Aug 2023.